1. "2010"
Formats
  1. Journal Article (2028)
  2. Meeting Abstract (717)
  3. Book Section (199)
  4. Book Whole (15)
  5. Conference Paper (10)
Groups
  1. Department of Medicine (846)
  2. Surgery (812)
  3. GSK Faculty (604)
  4. Sloan Kettering Institute Faculty (501)
  5. Solid Tumor Oncology Division (494)
  6. Survivorship Research (462)

More Groups

People
  1. Richard Barakat (59)
  2. Dennis Chi (58)
  3. Victor Reuter (57)
  4. Nadeem Abu-Rustum (53)
  5. Peter Scardino (49)
  6. Robert Soslow (49)

More People

Years
  1. 2010 (2969)
Publications
  1. Journal of Clinical Oncology (283)
  2. Cancer Research (79)
  3. Blood (78)
  4. International Journal of Radiation Oncology, Biology, Physics (78)
  5. Modern Pathology (72)
  6. Gynecologic Oncology (67)

More Publications

Publishers
  1. Elsevier Inc. (383)
  2. American Society of Clinical Oncology (284)
  3. Elsevier Science, Inc. (183)
  4. Springer (177)
  5. Lippincott Williams & Wilkins (153)
  6. Nature Publishing Group (144)

More Publishers

Results (2969)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase IB randomized, double-blinded, placebo-controlled, dose-escalation study of polyphenon E in women with a history of hormone receptor-negative breast cancer
    Meeting Abstract

    Crew, K. D.; Brown, P.; Greenlee, H.; Bevers, T. B.; Arun, B.; Hudis, C.; McArthur, H. L.; Vornik, L.; Cornelison, T. L.; Hershman, D. L.; more...
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Association of margin assessment method with reexcision rates in breast-conserving surgery (BCS)
    Meeting Abstract

    Choi, L.; Culpepper, C. K.; Goldberg, J. I.; Heerdt, A. S.; King, T. A.; Sclafani, L.; Reiner, A. S.; Patil, S.; Brogi, E.; Van Zee, K. J.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Relation of tumor pathologic and molecular features to outcome after surgical resection of localized primary gastrointestinal stromal tumor (GIST): Results of the intergroup phase III trial ACOSOG Z9001
    Meeting Abstract

    Corless, C. L.; Ballman, K. V.; Antonescu, C.; Blanke, C. D.; Blackstein, M. E.; Demetri, G. D.; von Mehren, M.; Maki, R. G.; Pisters, P. W.; DeMatteo, R. P.; more...
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Effect of lymphovascular Invasion and lymph node status on prognosis in patients with sweat gland carcinoma
    Meeting Abstract

    Crago, A. M.; Busam, K.; Brady, M. S.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • A phase II randomized study of ramucirumab (IMC-1121B) with or without dacarbazine (DTIC) in patients (pts) with metastatic melanoma (MM)
    Meeting Abstract

    Carvajal, R. D.; Wong, M. K.; Thompson, J. A.; Gordon, M. S.; Lewis, K. D.; Pavlick, A. C.; Wolchok, J. D.; Fox, F. E.; Schwartz, J. D.; Badikian, A. Y.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • A randomized, double-blind, controlled trial of methylphenidate for fatigue in patients with advanced cancer
    Meeting Abstract

    Bruera, E.; Valero, V.; Breitbart, W.; Guo, Y.; Palmer, J. L.; Cohen, M. Z.; Scott, C.; Lake, M. B.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Phase I dose-escalation study of AGS-1C4D4, an anti-PSCA human antibody in castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Carducci, M. A.; Eisenberger, M. A.; Denmeade, S. R.; Slovin, S. F.; Jakobovits, A.; Vincent, M.; Scher, H. I.; Morris, M. J.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Phase I pharmacokinetic (PK) and biodistribution study of radium-223 chloride in patients with castration resistant prostate cancer (CRPC) metastatic to bone
    Meeting Abstract

    Carrasquillo, J. A.; O'Donoghue, J. A.; Pandit-Taskar, N.; Rathkopf, D. E.; Aksnes, A.; Viner, C. L.; Hong, C. T.; Larson, S. M.; Scher, H. I.; Morris, M. J.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Venous thromboembolic events with chemotherapy plus bevacizumab: A pooled analysis of over 6,000 patients in randomized phase II and III studies
    Meeting Abstract

    Cassidy, J.; Saltz, L.; Van Cutsem, E.; Hedrick, E. E.; Lasserre, S.; Sirzen, F.; Rohr, U. P.; Hurwitz, H.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Hypogammaglobulinemia in pts receiving rituximab immunotherapy and the impact of rituximab maintenance
    Meeting Abstract

    Casulo, C.; Maragulia, J.; Zelenetz, A. D.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save